Lundbeck
HLUN-B.CO
#2578
Rank
A$8.72 B
Marketcap
$9.16
Share price
0.64%
Change (1 day)
30.22%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$3.71 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are A$3.71 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$3.33 B-5.35%
2022-12-31A$3.52 B2.61%
2021-12-31A$3.43 B-16.06%
2020-12-31A$4.09 B-10.41%
2019-12-31A$4.57 B139.99%
2018-12-31A$1.90 B21.8%
2017-12-31A$1.56 B-24.27%
2016-12-31A$2.06 B-18.12%
2015-12-31A$2.52 B4.37%
2014-12-31A$2.41 B14.52%
2013-12-31A$2.11 B47.87%
2012-12-31A$1.42 B8.28%
2011-12-31A$1.31 B9%
2010-12-31A$1.20 B-32.25%
2009-12-31A$1.78 B33.73%
2008-12-31A$1.33 B15.99%
2007-12-31A$1.15 B5.14%
2006-12-31A$1.09 B22.29%
2005-12-31A$0.89 B3.68%
2004-12-31A$0.86 B